30.06.2013 Views

How does the operation of PHARMAC's 'Community Exceptional ...

How does the operation of PHARMAC's 'Community Exceptional ...

How does the operation of PHARMAC's 'Community Exceptional ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

The Commerce Act gives protections and opportunities to test <strong>the</strong> fairness <strong>of</strong><br />

<strong>the</strong> commercial and retail market by injunctions and o<strong>the</strong>r legal remedies.<br />

These legal proceedings can be taken by persons or organisations likely to<br />

suffer damages by reason <strong>of</strong> contravention <strong>of</strong> <strong>the</strong> Commerce Act. The<br />

Commerce Commission 30 is established as an independent authority to protect<br />

<strong>the</strong> consumer from price-fixing and o<strong>the</strong>r anti-competitive behaviour.<br />

The Commerce Commissioner must provide surveillance and vigilance,<br />

watching trading companies and pr<strong>of</strong>essional bodies to ensure <strong>the</strong>y all act<br />

within an agreed set <strong>of</strong> rules. The Commerce Commission has considerable<br />

remedies available to it to redress any breaches <strong>of</strong> <strong>the</strong> Commerce Act. The<br />

RMI claimed that <strong>the</strong>se remedies have been swept away by excessive breadth<br />

and width <strong>of</strong> <strong>the</strong> immunity provisions provided to PHARMAC in Clause 6 <strong>of</strong> <strong>the</strong><br />

NZPHD Bill.<br />

The submission made by <strong>the</strong> Royal New Zealand College <strong>of</strong> General<br />

Practitioners also made <strong>the</strong> point that <strong>the</strong> Bill should more clearly state that<br />

PHARMAC’s objective was to achieve quality patient outcomes and not only<br />

price control (PB/ 14 The Royal NZ College <strong>of</strong> General Practitioners, 2000).<br />

The owners and managers <strong>of</strong> New Zealand private hospitals, <strong>the</strong> New Zealand<br />

Private Hospitals Association (NZPHA) agreed with <strong>the</strong> RMI that <strong>the</strong> exemption<br />

from <strong>the</strong> Commerce Act should be limited and only available to transactions<br />

between <strong>the</strong> DHBs and public health organisations, by application to <strong>the</strong><br />

Commerce Commission (PB/57 New Zealand Private Hospitals Association,<br />

2000). Lexchin and Caygill (2000) submitted that in relation to <strong>the</strong> argument <strong>of</strong><br />

whe<strong>the</strong>r PHARMAC should have a wide or narrow exemption, that “economic<br />

efficiency is not <strong>the</strong> only goal <strong>of</strong> <strong>the</strong> Commerce Act” (Lexchin & Caygill, 2000).<br />

They described <strong>the</strong>ir belief that economic efficiency was a desirable outcome<br />

from competition and health equity outcomes, in relation to pharmaceuticals, as<br />

also important. Lexchin and Cagyill’s submission pointed out to <strong>the</strong> Select<br />

Committee that <strong>the</strong> Commerce Act seeks to promote competition, by prohibiting<br />

contracts or arrangements that substantially lessen competition. The misuse <strong>of</strong><br />

a dominant position in <strong>the</strong> market <strong>does</strong> not necessarily create or prevent<br />

30 The Commerce Commission is a legal entity with significant powers to investigate and remedy anticompetitive trade<br />

practices. The Commission’s website is http://www.comcom.govt.nz/<br />

116

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!